(Q52713598)

6 May 2018

title

Inhibition by six somatostatin analogs of plasma growth hormone levels stimulated by thiamylal and morphine in the rat. (English)

1 reference

6 May 2018

author

Andrew Schally

5

1 reference

6 May 2018

Akira Arimura

4

object named as

Arimura A

1 reference

6 May 2018

David H. Coy

3

object named as

Coy DH

1 reference

6 May 2018

author name string

Ferland L

1

1 reference

6 May 2018

Labrie F

2

1 reference

6 May 2018

publication date

1 January 1976

1 reference

6 May 2018

Molecular and Cellular Endocrinology

published in

1 reference

6 May 2018

volume

4

1 reference

6 May 2018

issue

2

1 reference

6 May 2018

page(s)

79-88

1 reference

6 May 2018

Inhibition of growth hormone secretion in the rat by synthetic somatostatin

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Effects of somatostatin on the secretion of thyrotropin and prolactin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Radioimmunoassayable growth hormone in the rat pituitary gland: effects of age, sex and hormonal state

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition of Glucagon and Insulin Secretion by Somatostatin in the Rat Pancreas Perfusedin Situ

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition of Gastrin Release by Somatostatin in Vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Effect of Synthetic Somatotropin Release Inhibiting Factor on the Increase in Plasma Growth Hormone Elicited by L-Dopa in the Dog

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition of insulin secretion by somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition of growth hormone release in humans by somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibitory effect of somatostatin (SRIF) on the release of growth hormone (GH) induced in the rat by electrical stimulation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Growth hormone and ACTH secretion: evidence for an inverse relationship in rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Some Actions of Growth Hormone Release Inhibiting Factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Acute suppression of insulin and glucose levels by synthetic somatostatin in normal human subjects

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon Secretion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Regulation of Immunoreactive Growth Hormone Secretion in Male Rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Somatostatin Inhibition of Epinephrine-Induced Glucagon Secretion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Direct inhibition of insulin secretion by synthetic somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Growth hormone release inhibiting hormone in acromegaly

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Solid phase synthesis of growth hormone-release inhibiting factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

A Stimulatory Test for Growth Hormone Release in the Rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0303-7207(76)90028-9

Identifiers

DOI

10.1016/0303-7207(76)90028-9

1 reference

6 May 2018

1 reference

6 May 2018